As sub-Saharan countries struggle with the current burden of diabetes, new estimates suggest that costs associated with the disease could more than double and may reach up to US$59.3 billion per year by 2030, if type 2 diabetes cases continue to increase. The region is ill-prepared to cope with a growing health burden.
The statement is endorsed by the head of UCT’s Division of Forensic Medicine Professor Lorna Martin, who is a member of this committee.
Access to essential CVD medicines is worryingly low globally and particularly in low- and middle-income countries (LMICs), where some of the barriers to CVD medicines access include poor access to health care facilities, low availability, poor quality of medication and unaffordability.
For the first time in history more children in the world are overweight and obese than under-nourished and stunted, said UCT’s Professor Vicky Lambert following the release of the Healthy Active Kids South Africa Report Card (HAKSA) 2016.